Physician profile
Eric Kusseluk
NPI 1235283367
$5,013.66
in general payments reported to CMS, 2019-2025
19 companies · $2,291 in 2025
The $2,291 reported for 2025 was more than what 79% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.47 · 2020: $35.53 · 2021: $31.30 · 2022: $138 · 2023: $737 · 2024: $1,769 · 2025: $2,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,681 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,681.24 |
| Education | $115.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $826.31 | 2019-2025 | |
| Janssen Biotech, INC. | $824.18 | 2022-2025 | Tremfya |
| Pfizer INC. | $621.34 | 2023-2025 | |
| Genzyme Corporation | $579.72 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $417.08 | 2023-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $363.36 | 2024-2025 | |
| Galderma Laboratories, L.P. | $280.43 | 2023-2025 | Nemluvio, Aklief |
| Leo Pharma INC. | $218.99 | 2024-2025 | Adbry, Anzupgo |
| Incyte Corporation | $204.04 | 2023-2025 | Opzelura |
| Amgen INC. | $184.68 | 2023-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $121.70 | 2023-2025 | Absorica Ld, Winlevi |
| Regeneron Healthcare Solutions, INC. | $89.28 | 2022-2025 | Libtayo |
| Allergan, INC. | $84.46 | 2020-2022 | |
| Arcutis Biotherapeutics, INC. | $61.25 | 2024-2025 | Zoryve |
| Ucb, INC. | $48.71 | 2023-2024 | Cimzia, Bimzelx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $29.79 | 2025 | |
| Almirall LLC | $25.00 | 2025 | Seysara |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.77 | 2023 | Jublia |
| Journey Medical Corporation | $13.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kusseluk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.